title: [Effects of injection of Huangqi injectio into Zusanli (ST 36) on immune function in the patient of schizophrenia].
abstract: OBJECTIVE
  To study on effects of injection of Huangqi Injectio into Zusanli (ST 36) on the hospital infection and immune function in the patient of schizophrenia.
  
  
  METHODS
  Thirty inpatients of chronic schizophrenia were treated with injection of Huangqi Injectio into bilateral Zusanli (ST 36), 2 mL each point, thrice each week, for 8 weeks. Relative immune indexes and the hospital infection were investigated.
  
  
  RESULTS
  The hospital infection and the sub-infection were 4 cases (13.3%), 7 cases-times (23.3%) in the injection group; and 9 cases (15.0%), 19 cases-times (31.7%) in the control group, respectively, with no significant difference between the two groups (P>0.05). The drug-administration duration was 7.77 days/case and 11.87 days/case in the two groups, respectively (P<0.01). In the injection group, as compared with that of last 3 years the duration was 7.77 days/case and 14.08 days/case (P<0.01). IgG, IgA, IgM and T-cell subgroups did not have significant changes, but there was the most different value before and after injection in SIL-2R of the no-infection group, and the longer the drug administration duration, the smaller the different values.
  
  
  CONCLUSIONS
  Injection of Huangqi Injectio into Zusanli (ST 36) has definite effect for prevention of the hospital infection in inpatients of chronic schizophrenia, and SIL-2R is a valuable index for investigation of the hospital of infection.
authors.affiliation: Wutaishan Hospital of Yangzhou, Jiangsu 225003, China.
authors.forename: Bing-ru
authors.initials: BR
authors.lastname: Zhang
authors.forename: Su
authors.initials: S
authors.lastname: Li
authors.forename: Pei-yun
authors.initials: PY
authors.lastname: Yuan
authors.forename: Xiao-bin
authors.initials: XB
authors.lastname: Zhang
authors.forename: Li-xin
authors.initials: LX
authors.lastname: Cheng
authors.forename: Hong-hui
authors.initials: HH
authors.lastname: Zhou
authors.forename: Chao-yun
authors.initials: CY
authors.lastname: Zhou
authors.forename: Xiao-yu
authors.initials: XY
authors.lastname: Liu
authors.forename: Xiao-ling
authors.initials: XL
authors.lastname: Wang
authors.forename: Gui-zhen
authors.initials: GZ
authors.lastname: Tian
authors.forename: Qi-gen
authors.initials: QG
authors.lastname: Lin
authors.forename: Wei-wei
authors.initials: WW
authors.lastname: Sha
mesh_terms: D015669:Acupuncture Points; D000328:Adult; D000368:Aged; D027883:Astragalus Plant; D027885:Astragalus propinquus; D003428:Cross Infection / Q000517:prevention & control*; D004365:Drugs, Chinese Herbal / Q000008:administration & dosage*; D006801:Humans; D007136:Immunoglobulins / Q000097:blood; D008297:Male; D008875:Middle Aged; D015375:Receptors, Interleukin-2 / Q000097:blood; D012559:Schizophrenia / Q000276:immunology*; D016176:T-Lymphocyte Subsets / Q000276:immunology
chemical_list: D004365:Drugs, Chinese Herbal; D007136:Immunoglobulins; D015375:Receptors, Interleukin-2; C027492:Huang Qi